PSIL News and Press, AdvisorShares Psychedelics ETF

2024-05-23 12:15:00 ET Summary Regulatory risk in the psychedelic industry is decreasing, which is a positive sign for investors. Institutional investors are becoming more willing to invest in leading psychedelic companies through private placements. Analyst Alex Carchidi disc...

2024-05-07 05:54:17 ET More on psychedelic therapies MindMed: Breakthrough Status From FDA For LSD Therapy COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way? Mind Medicine: GAD Program Success Continues With BTD MindMed releases promising data on LSD-...

2023-07-16 18:00:00 ET Summary Alex Carchidi returns to update investors on the psychedelics industry. Collapse, consolidation, and why you shouldn't bet on just 1 stock. Compass Pathways' timeline for clinical trials; Atai and Cybin's recent wins. Alex Carchidi For ...

2023-07-15 18:06:24 ET Psychedelic stocks have taken it on the chin lately, with equity prices way down. Investors will have to be nimble and focus on individual stock picking, according to analyst Alex Carchidi. Speaking on Seeking Alpha's Investing Experts podcast, Carchi...

2023-07-13 12:35:00 ET Summary Will tough times continue for psychedelic stocks? Analyst Alex Carchidi shares his views on the sector and specific stocks like Compass Pathways, Atai and Cybin. Inevitability of big pharma entering the space. Listen below or on the g...

2023-03-26 21:00:00 ET Summary Dr. Julie Holland on why cannabis is a psychedelic. The biggest risk in psychedelic treatment. Investing in the industry. For further details see: Cannabis Is A Psychedelic - Dr. Julie Holland

2023-03-05 15:00:00 ET Summary Mental health may be our biggest health issue and traditional medicine has had limited success in treating it. Psychedelic compounds have been healing people for thousands of years but there are challenges around how to properly service the public. ...

Summary There have been some exciting developments in the research around the medicinal potential of psychedelic compounds. Despite a potential opportunity for disruption, investors should keenly understand the unique risks to biotechnology plays before investing in the space. Given...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Psychedelics stocks are becoming increasingly mainstream, in part due to changing social attitudes. Psychedelic drugs “are a loosely grouped class of drugs that are able to induce altered thoughts and sensory perce...

AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX) PR Newswire Designed for sophisticated investors, MSOX seeks investment returns two-times the daily performance of the AdvisorShares Pure US Cannabis ETF (Ticker: MSOS) ...